Adoptive transfers of low numbers of naïve TRP-1-specific T cells into wild-type mice results in overt vitiligo and potent rejection of established B16 melanoma when given in combination with vaccine and IL-2 [52], irradiation and anti-CTLA-4 [73], or in lymphopenic hosts [72]. This evidence concerns the gene CTLA4 and vitiligo.